Appel NM[au] - Search Results

Year	Number of Results
1977	1
1980	1
1981	5
1983	1
1984	1
1986	4
1987	3
1988	2
1989	2
1990	6
1991	3
1992	2
1994	1
1997	3
1998	1
1999	2
2001	2
2007	1
2015	1
2021	0

1

Approaches to the development of medications for the treatment of methamphetamine dependence.

Vocci FJ, Appel NM. Vocci FJ, et al. Among authors: appel nm. Addiction. 2007 Apr;102 Suppl 1:96-106. doi: 10.1111/j.1360-0443.2007.01772.x. Addiction. 2007. PMID: 17493058 Review.

2

Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs.

Appel NM, Li SH, Holmes TH, Acri JB. Appel NM, et al. J Pharmacol Exp Ther. 2015 Sep;354(3):484-92. doi: 10.1124/jpet.115.224121. Epub 2015 Jul 15. J Pharmacol Exp Ther. 2015. PMID: 26177654 Free PMC article.

3

Receptor pharmacology of MDMA and related hallucinogens.

Teitler M, Leonhardt S, Appel NM, De Souza EB, Glennon RA. Teitler M, et al. Among authors: appel nm. Ann N Y Acad Sci. 1990;600:626-38; discussion 638-9. doi: 10.1111/j.1749-6632.1990.tb16915.x. Ann N Y Acad Sci. 1990. PMID: 1979215

4

Classical and contemporary histochemical approaches for evaluating central nervous system microanatomy.

Appel NM. Appel NM. Ann N Y Acad Sci. 1997 May 30;820:14-28. doi: 10.1111/j.1749-6632.1997.tb46186.x. Ann N Y Acad Sci. 1997. PMID: 9237446 Review. No abstract available.

5

Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited.

Simpson IA, Appel NM, Hokari M, Oki J, Holman GD, Maher F, Koehler-Stec EM, Vannucci SJ, Smith QR. Simpson IA, et al. Among authors: appel nm. J Neurochem. 1999 Jan;72(1):238-47. doi: 10.1046/j.1471-4159.1999.0720238.x. J Neurochem. 1999. PMID: 9886075 Free article.

6

Mu receptors at discrete hypothalamic and brainstem sites mediate opioid peptide-induced increases in central sympathetic outflow.

Appel NM, Kiritsy-Roy JA, van Loon GR. Appel NM, et al. Brain Res. 1986 Jul 16;378(1):8-20. doi: 10.1016/0006-8993(86)90281-7. Brain Res. 1986. PMID: 3017504

7

beta-Endorphin-induced stimulation of central sympathetic outflow: inhibitory modulation by central noradrenergic neurons.

Appel NM, Van Loon GR. Appel NM, et al. J Pharmacol Exp Ther. 1986 Jun;237(3):695-701. J Pharmacol Exp Ther. 1986. PMID: 2940358

8

Beta-endorphin-induced increases in plasma epinephrine, norepinephrine and dopamine in rats: inhibition of adrenomedullary response by intracerebral somatostatin.

Van Loon GR, Appel NM, Ho D. Van Loon GR, et al. Among authors: appel nm. Brain Res. 1981 May 11;212(1):207-14. doi: 10.1016/0006-8993(81)90053-6. Brain Res. 1981. PMID: 6112047

9

Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in rats.

Appel NM, Owens MJ, Culp S, Zaczek R, Contrera JF, Bissette G, Nemeroff CB, De Souza EB. Appel NM, et al. Endocrinology. 1991 Jun;128(6):3237-46. doi: 10.1210/endo-128-6-3237. Endocrinology. 1991. PMID: 1645265

10

Muscarinic acetylcholine receptor subtype mRNA expression and ligand binding in the aged rat forebrain.

Blake MJ, Appel NM, Joseph JA, Stagg CA, Anson M, de Souza EB, Roth GS. Blake MJ, et al. Among authors: appel nm. Neurobiol Aging. 1991 May-Jun;12(3):193-9. doi: 10.1016/0197-4580(91)90097-4. Neurobiol Aging. 1991. PMID: 1876225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results